Analysis of Western European Molecular Imaging Market, Forecast to 2022
Improvements in Quantitation, New Clinical Applications, and Rising Prevalance of Cancer Keeps Market on the Upward Growth Curve
01-Aug-2018
Europe
Market Research
MD6E-01-00-00-00
HC03055-EU-MR_22161
This study takes a look at the Western European molecular imaging industry. The geographic scope of the market includes the United Kingdom, Germany, Italy, Spain, France, Scandinavia, and Benelux. The market is expected to experience a compound annual growth rate (CAGR) of 4.5 percent during 2017 to 2022, primarily driven by the growing incidence of cancer - with breast cancer and lung cancer being the most common cancers - and the continuing shift from single modalities to hybrid imaging. France, Germany, and Italy are hotspots for immediate future, followed by the steadily growing markets of Spain, Scandinavia, and Benelux.
Apart from the rising incidence of cancer, the greater availability of novel radiotracers and higher quantitation will drive the molecular imaging market. On the other hand, the price sensitivity of purchasers due to insufficient reimbursement and competition from other imaging modalities will continue to restrain growth.
France is the fastest growing market in Western Europe due to its high gross domestic product (GDP) spending on oncology screening programs. Italy and Germany are expected to be the second and third fastest due to the high incidence of cancer and increasing government initiatives. Spain, Benelux, and Scandinavia are forecast to grow steadily, while the United Kingdom is likely to be the slowest due to budgetary constraints.
There has been greater focus on PET/CT systems over SPECT/CT over the last few years and this trend will continue in the forecast period. Top market participants are anticipated to continue placing greater emphasis on premium modalities.
The PET/CT segment will experience the highest growth, while more stable growth is expected for the SPECT/CT segment. The latter segment has shrunken due to past shortages of Tc-99m, concerns over stability of future supply, improvements in PET MPI, and lower quantitation accuracy than PET. However, over the last few years, improvements in its technology and quantitation accuracy is expected to drive growth.
SPECT/CT has traditionally been used for cardiac imaging, while PET/CT has primarily been used for oncology imaging. This is set to change as advancements in PET/CT and SPECT/CT technologies, coupled with the launch of novel radiopharmaceuticals, will see molecular imaging applied across new clinical areas such as orthopedics and neurology.
Key Findings
- Research Methodology
Scope of the Study—Molecular Imaging
Market Engineering Measurements—Total Molecular Imaging Market
Market Engineering Measurements—PET/CT
Market Engineering Measurements—SPECT/CT
Market Engineering Measurements—SPECT
CEO’s Perspective
3 Big Predictions
Scope of this Study
Molecular Imaging—Definition
Market Drivers
Market Restraints
Market Engineering Measurements
Unit Shipment Forecast
Total Molecular Imaging Market Revenue Forecast
Revenue Forecast by Segment
Percent Revenue Forecast by Country
Revenue Forecast by Country
Shift in Focus from Standalone to Hybrid Imaging
Role of Molecular Imaging in Personalized Medicine
PET Scanning and Alzheimer’s Disease
5 Major Growth Opportunities
Strategic Imperatives for Success and Growth
Market Engineering Measurements
Unit Shipment Forecast
Revenue Forecast
Market Share
Market Share Analysis
Germany Market Analysis
Unit Shipment Forecast
Revenue Forecast
Segment Revenue Forecast
3 Big Predictions
Legal Disclaimer
Market Engineering Methodology
Installed Base of PET and PET/CT in Total Europe
Density of PET and PET/CT in Western Europe
List of Exhibits
- 1. Total Molecular Imaging Market: Key Market Drivers, Western Europe, 2018–2022
- 2. Total Molecular Imaging Market: Applications Radiotracers, Global, 2017
- 3. Total Molecular Imaging Market: Quantitation Software Developed by Market Participants, Global, 2017
- 4. Total Molecular Imaging Market: Key Market Restraints, Western Europe, 2018–2022
- 5. Total Molecular Imaging Market: Market Engineering Measurements, Western Europe, 2017
- 6. Total Molecular Imaging Market: Revenue Forecast by Country, Western Europe, 2016–2022
- 7. PET/CT Equipment Segment: Market Engineering Measurements, Western Europe, 2017
- 8. SPECT/CT Equipment Segment: Market Engineering Measurements, Western Europe, 2017
- 9. SPECT Equipment Segment: Market Engineering Measurements, Western Europe, 2017
- 10. Total Molecular Imaging Market: Installed Base of PET / PET/CT—Number of Installed Units by Age, Europe, 2008, 2011, 2013, and 2015
- 1. Total Molecular Imaging Market: Market Engineering Measurements, Western Europe, 2017
- 2. PET/CT Equipment Segment: Market Engineering Measurements, Western Europe, 2017
- 3. SPECT/CT Equipment Segment: Market Engineering Measurements, Western Europe, 2017
- 4. SPECT Equipment Segment: Market Engineering Measurements, Western Europe, 2017
- 5. Total Molecular Imaging Market: Age Standardised Rate (ASR) for Cancer, Western Europe, 2016
- 6. Total Molecular Imaging Market: Unit Shipment Forecast, Western Europe, 2016–2022
- 7. Total Molecular Imaging Market: Revenue Forecast, Western Europe, 2016–2022
- 8. Total Molecular Imaging Market: Revenue Forecast by Segment, Western Europe, 2016–2022
- 9. Total Molecular Imaging Market: Percent Revenue Forecast by Country, Western Europe, 2016–2022
- 10. Total Molecular Imaging Market: Major Growth Opportunitites, Western Europe, 2016–2022
- 11. PET/CT Equipment Segment: Unit Shipment Forecast, Western Europe, 2016–2022
- 12. PET/CT Equipment Segment: Revenue Forecast, Western Europe, 2016–2022
- 13. PET/CT Equipment Segment: Percent Unit Breakdown, Western Europe, 2017
- 14. SPECT/CT Equipment Segment: Unit Shipment Forecast, Western Europe, 2016–2022
- 15. SPECT/CT Equipment Segment: Revenue Forecast, Western Europe, 2016–2022
- 16. SPECT/CT Equipment Segment: Percent Unit Breakdown, Western Europe, 2017
- 17. SPECT Equipment Segment: Unit Shipment Forecast, Western Europe, 2016–2022
- 18. SPECT Equipment Segment: Revenue Forecast, Western Europe, 2016–2022
- 19. SPECT Equipment Segment: Percent Unit Breakdown, Western Europe, 2017
- 20. Molecular Imaging Market: Unit Shipment Forecast, Germany, 2016–2022
- 21. Molecular Imaging Market: Revenue Forecast, Germany, 2016–2022
- 22. Molecular Imaging Market: Revenue Forecast by Segment, Germany, 2016–2022
- 23. Molecular Imaging Market: Unit Shipment Forecast, the United Kingdom, 2016–2022
- 24. Molecular Imaging Market: Revenue Forecast, the United Kingdom, 2016–2022
- 25. Molecular Imaging Market: Revenue Forecast by Segment, the United Kingdom, 2016–2022
- 26. Molecular Imaging Market: Unit Shipment Forecast, France, 2016–2022
- 27. Molecular Imaging Market: Revenue Forecast, France, 2016–2022
- 28. Molecular Imaging Market: Revenue Forecast by Segment, France, 2016–2022
- 29. Molecular Imaging Market: Unit Shipment Forecast, Spain, 2016–2022
- 30. Molecular Imaging Market: Revenue Forecast, Spain, 2016–2022
- 31. Molecular Imaging Market: Revenue Forecast by Segment, Spain, 2016–2022
- 32. Molecular Imaging Market: Unit Shipment Forecast, Italy, 2016–2022
- 33. Molecular Imaging Market: Revenue Forecast, Italy, 2016–2022
- 34. Molecular Imaging Market: Revenue Forecast by Segment, Italy, 2016–2022
- 35. Molecular Imaging Market: Unit Shipment Forecast, Scandinavia, 2016–2022
- 36. Molecular Imaging Market: Revenue Forecast, Scandinavia, 2016–2022
- 37. Molecular Imaging Market: Revenue Forecast by Segment, Scandinavia, 2016–2022
- 38. Molecular Imaging Market: Unit Shipment Forecast, Benelux, 2016–2022
- 39. Molecular Imaging Market: Revenue Forecast, Benelux, 2016–2022
- 40. Molecular Imaging Market: Revenue Forecast by Segment, Benelux, 2016–2022
- 41. Total Molecular Imaging Market: PET and PET/CT Units Density, Western Europe, 2017
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
16 Nov 2026 | North America | Frost Radar
Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026
This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...
03 Nov 2026 | North America | Market Research
Enterprise Imaging Market, United States, 2025–2030
Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...
02 Nov 2026 | Global | Market Research
Continuous Glucose Monitoring Market, Global, 2026
The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...
28 Oct 2026 | Global | Frost Radar
Frost Radar™: Health Monitoring Wearable Solutions, 2026
The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...
26 Oct 2026 | Global | Technology Research
Game-Changing Innovations Transforming Cardiovascular Care
The study analyzes game-changing technologies transforming cardiovascular care across diagnosis, image-guided intervention, functional assessment, clinical workflow, and longitudinal patient monitoring. The analysis covers five segments: diagnostic imaging and AI-enabled cardiac assessment; interve...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.